Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

BAX

Baxter Intl

NYSE

Real-time Quotes | Nasdaq Last Sale

86.28

+0.29

+0.34%

After Hours: 86.28 0 0.00% 18:26 01/21 EST

OPEN

86.65

PREV CLOSE

85.99

HIGH

86.82

LOW

85.51

VOLUME

2.35M

TURNOVER

52 WEEK HIGH

88.91

52 WEEK LOW

73.12

MARKET CAP

43.20B

P/E (TTM)

36.21

Inspirion Wealth Advisors, Llc Buys Janus Henderson Mortgage-Backed Securities ETF, Zscaler ...

Investment company Inspirion Wealth Advisors, Llc (Current Portfolio) buys Janus Henderson Mortgage-Backed Securities ETF, Zscaler Inc, Janus Henderson AAA CLO ETF, Hartford Total Return Bond ETF, WisdomTree U.S.

GuruFocus.com · 15h ago

Catalent (CTLT) to Advance Oral Drug Development With New Launch

Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to complete clinical studies.

Zacks · 1d ago

Here's Why You Should Retain Chemed (CHE) Stock for Now

Investors are optimistic about Chemed (CHE), given impressive performance of the Roto-Rooter arm and solid growth in VITAS admissions.

Zacks · 2d ago

Abiomed (ABMD) Reports Positive Data Backing preCARDIA System

Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and increasing urine output in ADHF patients.

Zacks · 2d ago

Is ATI Physical Therapy, Inc. (ATIP) Outperforming Other Medical Stocks This Year?

Here is how ATI Physical Therapy, Inc. (ATIP) and Baxter International (BAX) have performed compared to their sector so far this year.

Zacks · 2d ago

PacBio (PACB) to Leverage Google's Deep Learning Technologies

PacBio's (PACB) research collaboration with Google will likely enhance its HiFi Sequencing technology to extract greater value from genomic data.

Zacks · 3d ago

Here's Why You Should Invest in Neogen (NEOG) Stock Now

Neogen's (NEOG) better-than-expected Q2 revenues and robust growth across Food Safety & Animal Safety businesses instill investor confidence.

Zacks · 3d ago

Best Momentum Stocks to Buy for January 18th

BAX, F, and EGO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 18, 2022

Zacks · 3d ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of BAX. Analyze the recent business situations of Baxter Intl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

17.65%Strong Buy

58.82%Buy

23.53%Hold

0.00%Under-perform

0.00%Sell

Analyst Price Target

The average BAX stock price target is 97.80 with a high estimate of 110.00 and a low estimate of 88.00.

High110.00

Average97.80

Low88.00

Current 86.28

EPS

Actual

Estimate

0.260.520.771.03

Q4 2020

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Institutional Holdings

Institutions: 1.50K

Institutional Holdings: 463.52M

% Owned: 92.58%

Shares Outstanding: 500.69M

TypeInstitutionsShares

Increased

356

29.70M

New

5.42M

Decreased

382

31.04M

Sold Out

4.59M

Performance
Asset Allocation
Dividend History

No Data

Industry

Medical Equipment, Supplies & Distribution

-0.93%

Healthcare Equipment & Supplies

-1.50%

Key Executives

Chairman/President/Chief Executive Officer/Director

Jose Almeida

Chief Financial Officer/Executive Vice President

James Saccaro

Chief Operating Officer/Executive Vice President

Giuseppe Accogli

Senior Vice President/General Counsel

Sean Martin

Senior Vice President/Director of Human Resources

Jeanne Mason

Senior Vice President

James Borzi

Senior Vice President

Cristiano Franzi

Senior Vice President

Andrew Frye

Senior Vice President

Jacqueline Kunzler

Lead Director/Independent Director

Albert Stroucken

Director

Nancy Schlichting

Independent Director

Thomas Chen

Independent Director

John Forsyth

Independent Director

Peter Hellman

Independent Director

Michael Mahoney

Independent Director

Patricia Morrison

Independent Director

Stephen Oesterle

Independent Director

Cathy Smith

Independent Director

Thomas Stallkamp

Independent Director

Amy Wendell

Independent Director

David Wilkes

Declaration Date Dividend Per Share Ex-Div Date: --
Dividend USD 0.28
12/02/2021; 07/12/2021
Dividend USD 0.28
09/02/2021; 05/03/2021
Dividend USD 0.28
06/03/2021; 02/16/2021
Dividend USD 0.245
02/25/2021; 11/16/2020
Dividend USD 0.245
12/03/2020; 07/14/2020
Dividend USD 0.245
08/28/2020; 05/05/2020
Dividend USD 0.245
06/04/2020; 02/18/2020
Dividend USD 0.22
02/27/2020; 11/19/2019
Dividend USD 0.22
12/05/2019; 07/16/2019
Dividend USD 0.22
08/29/2019; 05/07/2019
Dividend USD 0.22
06/06/2019; 02/19/2019
Dividend USD 0.19
02/28/2019; 11/13/2018
Dividend USD 0.19
11/30/2018; 07/17/2018
Dividend USD 0.19
08/30/2018; 05/08/2018
Dividend USD 0.19
05/31/2018; 02/20/2018
Dividend USD 0.16
03/01/2018; 11/14/2017
Dividend USD 0.16
11/30/2017; 07/18/2017
Dividend USD 0.16
08/30/2017; 05/02/2017
Dividend USD 0.16
05/31/2017; 02/21/2017
Dividend USD 0.13
03/01/2017

All
Financials
Insiders

About BAX

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.

Webull offers kinds of Baxter International Inc stock information, including NYSE:BAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BAX stock methods without spending real money on the virtual paper trading platform.